Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 3 | Virology Journal

Figure 3

From: The diversity of human papillomavirus infection among human immunodeficiency virus-infected women in Yunnan, China

Figure 3

Prevalence of HPV infection by duration of receiving ART group among HIV-infected women in Yunnan, China. *p value for trend of univariate analysis was <0.05. HPV, Human Papillomavirus. Carcinogenic HPV includes HPV 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59 and 68. Possibly carcinogenic HPV includes HPV 53, 66, 73 and 82. ART, Antiretroviral Therapy. With increasing duration on ART, p-value for trend for carcinogenic HPV and multiple carcinogenic HPV were 0.013 and 0.002, respectively.

Back to article page